Michael H Zeihen, MD | |
6308 8th Ave, Suite 2000, Kenosha, WI 53143-5031 | |
(262) 653-5300 | |
(262) 653-5412 |
Full Name | Michael H Zeihen |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 50 Years |
Location | 6308 8th Ave, Kenosha, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043266992 | NPI | - | NPPES |
30262200 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 19746 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kenosha Vna | Kenosha, WI | Home health agency |
Horizon Home Care And Hospice | Milwaukee, WI | Home health agency |
Hospice Alliance | Pleasant prairie, WI | Hospice |
United Hospital System | Kenosha, WI | Hospital |
Brookside Care Center | Kenosha, WI | Nursing home |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Froedtert South Inc | 9537071196 | 118 |
News Archive
Scientists led by Queen Mary University of London (QMUL) have developed a new type of synthetic bone graft that boosts the body's own ability to regenerate bone tissue and could produce better outcomes for patients.
Sorin Group, a global medical device company and a leader in the treatment of cardiovascular devices, is proud to announce the introduction of its VascuClear Endoscopic Vessel Harvesting (EVH) system to replace the existing EVH product offering.
ViroPharma Incorporated reported today its financial results for the fourth quarter and year ended December 31, 2009.
Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced their signing of a share purchase agreement under which Vétoquinol has agreed to purchase Bioniche's Animal Health business for the cash purchase price of CAD$61 million.
IASIS Healthcare® LLC today announced financial and operating results for the fiscal second quarter and six months ended March 31, 2010.
› Verified 8 days ago
Entity Name | Froedtert South Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558305284 PECOS PAC ID: 9537071196 Enrollment ID: O20031103000493 |
News Archive
Scientists led by Queen Mary University of London (QMUL) have developed a new type of synthetic bone graft that boosts the body's own ability to regenerate bone tissue and could produce better outcomes for patients.
Sorin Group, a global medical device company and a leader in the treatment of cardiovascular devices, is proud to announce the introduction of its VascuClear Endoscopic Vessel Harvesting (EVH) system to replace the existing EVH product offering.
ViroPharma Incorporated reported today its financial results for the fourth quarter and year ended December 31, 2009.
Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced their signing of a share purchase agreement under which Vétoquinol has agreed to purchase Bioniche's Animal Health business for the cash purchase price of CAD$61 million.
IASIS Healthcare® LLC today announced financial and operating results for the fiscal second quarter and six months ended March 31, 2010.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Michael H Zeihen, MD 6308 8th Ave, Suite 2000, Kenosha, WI 53143-5031 Ph: (262) 653-5300 | Michael H Zeihen, MD 6308 8th Ave, Suite 2000, Kenosha, WI 53143-5031 Ph: (262) 653-5300 |
News Archive
Scientists led by Queen Mary University of London (QMUL) have developed a new type of synthetic bone graft that boosts the body's own ability to regenerate bone tissue and could produce better outcomes for patients.
Sorin Group, a global medical device company and a leader in the treatment of cardiovascular devices, is proud to announce the introduction of its VascuClear Endoscopic Vessel Harvesting (EVH) system to replace the existing EVH product offering.
ViroPharma Incorporated reported today its financial results for the fourth quarter and year ended December 31, 2009.
Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced their signing of a share purchase agreement under which Vétoquinol has agreed to purchase Bioniche's Animal Health business for the cash purchase price of CAD$61 million.
IASIS Healthcare® LLC today announced financial and operating results for the fiscal second quarter and six months ended March 31, 2010.
› Verified 8 days ago
Hanna Mariani, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6308 8th Ave, Ste 3070, Kenosha, WI 53143 Phone: 262-656-3710 Fax: 262-656-3715 | |
Leilane U Sta Romana, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6127 Green Bay Rd, #200, Kenosha, WI 53142 Phone: 262-658-3706 Fax: 262-658-1751 | |
Raymond W Knight, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6308 8th Ave, Ste 2000, Kenosha, WI 53143 Phone: 262-653-5300 Fax: 262-653-5412 | |
Dr. Rodrigo Buencamino Mata Iii, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6123 Green Bay Rd, Suite 120, Kenosha, WI 53142 Phone: 262-652-2710 | |
Zebi Fatima, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-942-5600 | |
Timothy A. Sanborn, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6308 8th Ave, Kenosha, WI 53143 Phone: 262-653-3650 Fax: 262-656-3672 |